- Record: found
- Abstract: not found
- Article: not found
LBA23 Pembrolizumab (P) combined with chemotherapy (C) vs C alone as first-line (1L) therapy for advanced urothelial carcinoma (UC): KEYNOTE-361
A. Alva ,
T. Csőszi ,
M. Ozguroglu ,
N. Matsubara ,
L. Geczi ,
S.Y-S. Cheng ,
Y. Fradet ,
S. Oudard ,
C. Vulsteke ,
R. Morales Barrera ,
A. Fléchon ,
S. Gunduz ,
Y. Loriot ,
A. Rodriguez-Vida ,
R. Mamtani ,
E.Y. Yu ,
K. Nam ,
K. Imai ,
B.H. Moreno ,
T.B. Powles
September 2020
September 2020
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.